Join the free discord-https://xitter.cf/t.co/vCdww48mqd Haven’t had a losing month since August 2023. Up over 100 units this month!
Joined December 2022
- Tweets4.7K
- Following92
- Followers147
- Likes29.5K
SherLock Knows 🟧 retweeted
$QURE oh mamasita... strongly suggestive of four month window to get this all done with... $120+ or $200+ if it gets carried away
SherLock Knows 🟧 retweeted
$SKFG .62...
Looks like a great buy, picked some down here.
Called the TA and all the numbers posted on OTC markets are accurate and maintains the small DTC..
Outstanding Shares
9,948,330
08/12/2026
Restricted
8,300,000
08/12/2026
Unrestricted
1,648,330
08/12/2026
Held at DTC
1,648,330
08/12/2026
SherLock Knows 🟧 retweeted
$SKFG .62...
Looks like a great buy, picked some down here.
Called the TA and all the numbers posted on OTC markets are accurate and maintains the small DTC..
Outstanding Shares
9,948,330
08/12/2026
Restricted
8,300,000
08/12/2026
Unrestricted
1,648,330
08/12/2026
Held at DTC
1,648,330
08/12/2026
SherLock Knows 🟧 retweeted
$QURE getting a LTC buy signal now, shorter term points to 11/20 thru mid January '27, one pop towards the 200dma will get intermediate signal, and into mid November the 7week cycle triggers and now one month surge window opens for perfect time for high energy move
$SKFG ton of volume has been traded in and out past couple of sessions though.
SherLock Knows 🟧 retweeted
$NBIS BREAKING:
Nebius signed a preliminary framework with HUMAIN(One of Saudi Arabia's largest sovereign wealth funds) and DataVolt to be the anchor customer at NEOM's Oxagon AI campus.
The details:
• Up to 50MW, half of the first 100MW now under construction
• Phase 1 is planned at 360MW total
• Capacity comes online in phases starting Q4 2027
• Nebius is HUMAIN's first customer
• Signed at NVIDIA GTC Berlin
It's still preliminary, so not a done deal yet. But Saudi Arabia's sovereign fund is picking Nebius as its first customer.
$SKFG 8 red days in a row if we close down today, when will we go back to green streaks
SherLock Knows 🟧 retweeted
$NBIS
Triple bottom at$163
$275/$300 by end of year
SherLock Knows 🟧 retweeted
Elon says $SPCX is being hounded by hyperscalers for compute rentals
Says they could rent out their existing compute several times over if they said yes to everyone
Demand for compute is still insanely strong
SherLock Knows 🟧 retweeted
$NBIS SPCX earnings was the first bullish catalyst. I expect Meta to also beat and guide higher. There is nothing wrong with earnings only high rates.
SherLock Knows 🟧 retweeted
ELON SAYS GROK BOT REVENUE TO REACH BETWEEN $500B TO $1 TRILLION BY THE END OF 2027 $SPCX
I'm sorry, what????
SherLock Knows 🟧 retweeted
$PRAX $XBI LIFESCI (OUTPERFORM,$754.00 PT): Neurologist Survey (N=27): Unanimous Intent to Prescribe Ulixacaltamide, With ~50% of ET Patients Expected on Therapy at Steady State
$PRAX RJ raising EMERALD PoS and relu peak sales estimate, bringing PT to $945 from $765. Three stock-moving catalysts over next 6-12 months create what see as one of the most compelling setups in SMID biotech:
relutrigine’s Ph3 EMERALD readout in 4Q26 ulixa’s PDUFA date on January 29, 2027 and ulixa’s
launch in essential tremor in early 2027. analysis of ulixa’s regulatory package underpins our high conviction in ulixa approval, while
our diligence on relu’s heterogeneity risk and commercial opportunity leaves us more constructive on both its probability of success and
peak sales potential. On ulixa's launch, we believe very few SMID biotechs offer exposure to a potential mega blockbuster, particularly
at PRAX's valuation.
